June 17, 2020
We believe there is tremendous upside for investors by owning Epigenomics ahead of, what we expect to be, a positive CMS reimbursement decision by August 28th.
Nov 11, 2019
Big Pharma's familiarity with AR antagonism makes Essa a legitimate M&A candidate.
November 25, 2019
We are initiating on Acasti Pharma as a high risk investment ideas.